Fabio
12 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Public schools; opioid antagonist administration, etc. | Public schools; opioid antagonist procurement, possession, and administration; school board employee training and certification; opioid overdose prevention and reversal instruction; guidelines and requirements. Requires each local school board to develop, in accordance with the guidelines developed by the Department of Health in collaboration with the Department of Education, plans, policies, and procedures for (i) providing at each public secondary school that includes grades nine through 12 a program of instruction on opioid overdose prevention and reversal and for encouraging each student to complete such program of instruction prior to graduation; (ii) the procurement, placement, and maintenance in each public elementary and secondary school of a supply of opioid antagonists in an amount equivalent to at least two unexpired doses for the purposes of opioid overdose reversal; and (iii) the possession and administration of an opioid antagonist by any employee of the school board who is authorized by a prescriber and trained in the administration of an opioid antagonist, including policies (a) requiring each public elementary and secondary school to ensure that at least one employee is authorized by a prescriber and trained and certified in the administration of an opioid antagonist, (b) for partnering with a program administered or approved by the Department of Health to provide such training and certification, and (c) for maintaining records of each such trained and certified employee.The bill provides for the disciplinary, civil, and criminal immunity of any employee of a public school, school board, or local health department, regardless of whether such employee was trained or certified in opioid antagonist administration, for any act or omission made in connection with the good faith administration of an opioid antagonist for the purposes of opioid overdose reversal during regular school hours, on school premises, or during a school-sponsored activity, unless such act or omission was the result of gross neglect or willful misconduct. The bill requires each school board to adopt and each public elementary and secondary school to implement policies and procedures in accordance with the provisions of the bill and, in doing so, to utilize to the fullest extent possible programs offered by the Department of Health for the provision of opioid antagonist administration training and certification and opioid antagonist procurement.In addition, the bill modifies the school board employees who are authorized to administer opioid antagonists to include any school board employee who has completed training and is certified in the administration of an opioid antagonist by a program administered or authorized by the Department of Health.Finally, the bill directs the Department of Health and the Department of Education to collaborate to develop guidelines and policies for the implementation of the provisions of the bill and requires each school board to implement the provisions of the bill by the beginning of the 2025–2026 school year. This bill incorporates SB 387 and is identical to HB 732. | us/states/va | Virginia General Assembly | 2024 | SB 726 | Virginia SB 726 (2024) |
|
enacted |
|
5 | 51 | 10 | 2024-01-19 | 2024-04-04 | openstates | ocd-bill/80b8e5b1-39a6-4835-8e7f-916459376bda | https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+SB726 | 99db409271b69d236187b963fd1eb17df4f500a359d095986d66f72728ed0b44 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 726 (2024) — Public schools; opioid antagonist administration, etc.
Public schools; opioid antagonist procurement, possession, and administration; school board employee training and certification; opioid overdose prevention and reversal instruction; guidelines and requirements. Requires each local school board to develop, in accordance with the guidelines developed by the Department of Health in collaboration with the Department of Education, plans, policies, and procedures for (i) providing at each public secondary school that includes grades nine through 12 a program of instruction on opioid overdose prevention and reversal and for encouraging each student to complete such program of instruction prior to graduation; (ii) the procurement, placement, and maintenance in each public elementary and secondary school of a supply of opioid antagonists in an amount equivalent to at least two unexpired doses for the purposes of opioid overdose reversal; and (iii) the possession and administration of an opioid antagonist by any employee of the school board who is authorized by a prescriber and trained in the administration of an opioid antagonist, including policies (a) requiring each public elementary and secondary school to ensure that at least one employee is authorized by a prescriber and trained and certified in the administration of an opioid antagonist, (b) for partnering with a program administered or approved by the Department of Health to provide such training and certification, and (c) for maintaining records of each such trained and certified employee.The bill provides for the disciplinary, civil, and criminal immunity of any employee of a public school, school board, or local health department, regardless of whether such employee was trained or certified in opioid antagonist administration, for any act or omission made in connection with the good faith administration of an opioid antagonist for the purposes of opioid overdose reversal during regular school hours, on school premises, or during a school-sponsored activity, unless such act or omission was the result of gross neglect or willful misconduct. The bill requires each school board to adopt and each public elementary and secondary school to implement policies and procedures in accordance with the provisions of the bill and, in doing so, to utilize to the fullest extent possible programs offered by the Department of Health for the provision of opioid antagonist administration training and certification and opioid antagonist procurement.In addition, the bill modifies the school board employees who are authorized to administer opioid antagonists to include any school board employee who has completed training and is certified in the administration of an opioid antagonist by a program administered or authorized by the Department of Health.Finally, the bill directs the Department of Health and the Department of Education to collaborate to develop guidelines and policies for the implementation of the provisions of the bill and requires each school board to implement the provisions of the bill by the beginning of the 2025–2026 school year. This bill incorporates SB 387 and is identical to HB 732.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0519 (committee substitute) — source
- Committee substitute printed 24106276D-S1 (committee substitute) — source
- Committee substitute printed 24108379D-H1 (committee substitute) — source
- Presented and ordered printed 24104902D (committee substitute) — source
- SB726ER (committee substitute) — source
Votes
- Reported from Education and Health with substitute (15-Y 0-N) — 15–0 (pass) · upper
- Subcommittee recommends reporting with substitute (8-Y 0-N) — 8–0 (pass) · lower
- Reported from Education with substitute (22-Y 0-N) — 22–0 (pass) · lower
- Senate acceded to request (40-Y 0-N) — 40–0 (pass) · upper
- Constitutional reading dispensed (38-Y 0-N) — 38–0 (pass) · upper
- VOTE: Adoption (96-Y 0-N) — 95–0 (pass) · lower
- Read third time and passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- VOTE: Block Vote Passage (97-Y 0-N) — 96–0 (pass) · lower
- Conference report agreed to by Senate (40-Y 0-N) — 40–0 (pass) · upper
- House substitute rejected by Senate (0-Y 40-N) — 0–40 (fail) · upper
Sponsors
- Todd E. Pillion — primary (person)
- Stella G. Pekarsky — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-01-19 Presented and ordered printed 24104902D
introduction - 2024-01-19 Referred to Committee on Education and Health
referral-committee - 2024-01-24 Assigned Education and Health Sub: Public Education
referral-committee - 2024-01-25 Senate subcommittee amendments and substitutes offered
- 2024-02-01 Senate subcommittee amendments and substitutes offered
- 2024-02-01 Reported from Education and Health with substitute (15-Y 0-N)
committee-passage - 2024-02-01 Incorporates SB387 (Pekarsky)
- 2024-02-01 Committee substitute printed 24106276D-S1
substitution - 2024-02-02 Constitutional reading dispensed (38-Y 0-N)
- 2024-02-05 Read second time
reading-2 - 2024-02-05 Reading of substitute waived
- 2024-02-05 Committee substitute agreed to 24106276D-S1
substitution - 2024-02-05 Engrossed by Senate - committee substitute SB726S1
substitution - 2024-02-06 Read third time and passed Senate (39-Y 0-N)
passage, reading-3 - 2024-02-13 Placed on Calendar
- 2024-02-13 Read first time
reading-1 - 2024-02-13 Referred to Committee on Education
referral-committee - 2024-02-13 Impact statement from DPB (SB726S1)
- 2024-02-23 Assigned Education sub: K-12 Subcommittee
referral-committee - 2024-02-27 House subcommittee amendments and substitutes offered
- 2024-02-27 Subcommittee recommends reporting with substitute (8-Y 0-N)
substitution - 2024-02-28 Reported from Education with substitute (22-Y 0-N)
committee-passage - 2024-02-28 Committee substitute printed 24108379D-H1
substitution - 2024-02-28 Impact statement from DPB (SB726H1)
- 2024-03-01 Read second time
reading-2 - 2024-03-04 Read third time
reading-3 - 2024-03-04 Committee substitute agreed to 24108379D-H1
substitution - 2024-03-04 Engrossed by House - committee substitute SB726H1
substitution - 2024-03-04 Passed House with substitute BLOCK VOTE (97-Y 0-N)
passage - 2024-03-04 VOTE: Block Vote Passage (97-Y 0-N)
passage - 2024-03-05 House substitute rejected by Senate (0-Y 40-N)
- 2024-03-06 House insisted on substitute
substitution - 2024-03-06 House requested conference committee
referral-committee - 2024-03-07 Senate acceded to request (40-Y 0-N)
- 2024-03-07 Conferees appointed by Senate
- 2024-03-07 Senators: Pillion, VanValkenburg, Bagby
- 2024-03-07 Conferees appointed by House
- 2024-03-07 Delegates: Sewell, Reid, Freitas
- 2024-03-08 Amended by conference committee
- 2024-03-08 Conference report agreed to by Senate (40-Y 0-N)
committee-passage-favorable - 2024-03-08 Conference report agreed to by House (96-Y 0-N)
committee-passage-favorable - 2024-03-08 VOTE: Adoption (96-Y 0-N)
- 2024-03-25 Enrolled
enrolled - 2024-03-25 Bill text as passed Senate and House (SB726ER)
passage - 2024-03-25 Signed by President
passage - 2024-03-26 Signed by Speaker
passage - 2024-03-27 Enrolled Bill Communicated to Governor on March 27, 2024
enrolled - 2024-03-27 Governor's Action Deadline 11:59 p.m., April 8, 2024
executive-receipt - 2024-03-31 Impact statement from DPB (SB726ER)
- 2024-04-04 Approved by Governor-Chapter 519 (effective 7/1/24)
executive-signature - 2024-04-04 Acts of Assembly Chapter text (CHAP0519)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/80b8e5b1-39a6-4835-8e7f-916459376bda. Confidence: reported (aggregated from official Virginia legislature records).